A cardiac myocyte vascular endothelial growth factor paracrine pathway is required to maintain cardiac function

被引:302
作者
Giordano, FJ
Gerber, HP
Williams, SP
VanBruggen, N
Bunting, S
Ruiz-Lozano, P
Gu, YS
Nath, AK
Huang, Y
Hickey, R
Dalton, N
Peterson, KL
Ross, J
Chien, KR
Ferrara, N
机构
[1] Yale Univ, Sch Med, Boyer Ctr Mol Med, Cardovasc Genet Therapy Program,Dept Med, New Haven, CT 06520 USA
[2] Genentech Inc, S San Francisco, CA 94080 USA
[3] Univ Calif San Diego, Sch Med, Salk Program Mol Med, La Jolla, CA 92037 USA
关键词
D O I
10.1073/pnas.091415198
中图分类号
O [数理科学和化学]; P [天文学、地球科学]; Q [生物科学]; N [自然科学总论];
学科分类号
07 ; 0710 ; 09 ;
摘要
The role of the cardiac myocyte as a mediator of paracrine signaling in the heart has remained unclear. To address this issue, we generated mice with cardiac myocyte-specific deletion of the vascular endothelial growth factor gene, thereby producing a cardiomyocyte-specific knockout of a secreted factor. The hearts of these mice had fewer coronary microvessels, thinned ventricular walls, depressed basal contractile function, induction of hypoxia-responsive genes involved in energy metabolism, and an abnormal response to beta -adrenergic stimulation. These findings establish the critical importance of cardiac myocyte-derived Vascular endothelial growth factor in cardiac morphogenesis and determination of heart function. Further, they establish an adult murine model of hypovascular nonnecrotic cardiac contractile dysfunction.
引用
收藏
页码:5780 / 5785
页数:6
相关论文
共 34 条
[1]   Cardiac failure in transgenic mice with myocardial expression of tumor necrosis factor-α [J].
Bryant, D ;
Becker, L ;
Richardson, J ;
Shelton, J ;
Franco, F ;
Peshock, R ;
Thompson, M ;
Giroir, B .
CIRCULATION, 1998, 97 (14) :1375-1381
[2]   Resting myocardial flow in hibernating myocardium: validating animal models of human pathophysiology [J].
Canty, JM ;
Fallavollita, JA .
AMERICAN JOURNAL OF PHYSIOLOGY-HEART AND CIRCULATORY PHYSIOLOGY, 1999, 277 (01) :H417-H422
[3]   Impaired myocardial angiogenesis and ischemic cardiomyopathy in mice lacking the vascular endothelial growth factor isoforms VEGF164 and VEGF188 [J].
Carmeliet, P ;
Ng, YS ;
Nuyens, D ;
Theilmeier, G ;
Brusselmans, K ;
Cornelissen, I ;
Ehler, E ;
Kakkar, VV ;
Stalmans, I ;
Mattot, V ;
Perriard, JC ;
Dewerchin, M ;
Flameng, W ;
Nagy, A ;
Lupu, F ;
Moons, L ;
Collen, D ;
D'Amore, PA ;
Shima, DT .
NATURE MEDICINE, 1999, 5 (05) :495-502
[4]   Abnormal blood vessel development and lethality in embryos lacking a single VEGF allele [J].
Carmeliet, P ;
Ferreira, V ;
Breier, G ;
Pollefeyt, S ;
Kieckens, L ;
Gertsenstein, M ;
Fahrig, M ;
Vandenhoeck, A ;
Harpal, K ;
Eberhardt, C ;
Declercq, C ;
Pawling, J ;
Moons, L ;
Collen, D ;
Risau, W ;
Nagy, A .
NATURE, 1996, 380 (6573) :435-439
[5]  
COKER ML, 1999, AM J PHYSIOL, V277, pM777
[6]   Differential expression of platelet-endothelial cell adhesion molecule-1 (PECAM-1) in murine tissues [J].
Eppihimer, MJ ;
Russell, J ;
Langley, R ;
Vallien, G ;
Anderson, DC ;
Granger, DN .
MICROCIRCULATION, 1998, 5 (2-3) :179-188
[7]   HYPOXIA UP-REGULATES THE SYNTHESIS OF TGF-BETA-1 BY HUMAN DERMAL FIBROBLASTS [J].
FALANGA, V ;
QIAN, SW ;
DANIELPOUR, D ;
KATZ, MH ;
ROBERTS, AB ;
SPORN, MB .
JOURNAL OF INVESTIGATIVE DERMATOLOGY, 1991, 97 (04) :634-637
[8]   Heterozygous embryonic lethality induced by targeted inactivation of the VEGF gene [J].
Ferrara, N ;
CarverMoore, K ;
Chen, H ;
Dowd, M ;
Lu, L ;
OShea, KS ;
PowellBraxton, L ;
Hillan, KJ ;
Moore, MW .
NATURE, 1996, 380 (6573) :439-442
[9]  
Gerber HP, 1999, DEVELOPMENT, V126, P1149
[10]   A novel method for real time quantitative RT PCR [J].
Gibson, UEM ;
Heid, CA ;
Williams, PM .
GENOME RESEARCH, 1996, 6 (10) :995-1001